3rd Quarter - Termination

AVOQ, LLC for GINGKO BIOWORKS

Period 3rd Quarter 2021 Filed Oct 20, 2021 Signed by Steven Elmendorf

Official filing
Firm
AVOQ, LLC
Client
GINGKO BIOWORKS
Income
$40,000
Expenses
—
Terminated
Aug 31, 2021

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues relating to synthetic biology

LobbyistCovered position, as disclosed
STEVEN ELMENDORF —
BILL GHENT —
SHANTI STANTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Science/Technology SCI

Issues relating to synthetic biology

LobbyistCovered position, as disclosed
STEVEN ELMENDORF —
BILL GHENT —
SHANTI STANTON —

Contacted: SENATE; Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.